Industry Trend Analysis - Health System Modernisation Project To Provide Drugmaker Opportunities - MAR 2017
Emerging Europe February 2017 / Belarus / Industry
While Belarus has been highly successful at improving access to basic care over recent years given high levels of investment, there remain areas that require improvement. The World Bank's USD125mn...
Industry Trend Analysis - Short-Term Pain Will Provide Drugmakers With Long-Term Gain - SEPT 2016
Emerging Europe July 2016 / Belarus / Industry
Belarus will be an attractive market for both multinational pharmaceutical firms and medical device manufacturers in the long term. While in the short term, economic issues will repress growth and...
Industry Trend Analysis - Investment In Pharmaceutical Industry To Continue - JULY 2016
Emerging Europe June 2016 / Belarus / Industry
Belarus is well positioned to become an export hub for pharmaceuticals across the CEE region. Investment within the country's domestic drug production industry is increasing given the country's...
Industry Trend Analysis - Belarus Poised To Become Regional Pharmaceutical Export Hub - JUNE 2016
Emerging Europe May 2016 / Belarus / Industry
Indian investment into the Belarusian pharmaceutical market highlights the country's potential as an export hub for generic medicines across the CEE region. Government initiatives promoting local...
Industry Trend Analysis - Economic Reliance On Russia To Repress Healthcare Growth - APR 2016
Emerging Europe March 2016 / Belarus / Industry
Belarus's large burden of disease and ageing population will drive increasing demand for healthcare services in the country, providing drugmakers and medical device companies with revenue earning...
Industry Trend Analysis - Local Manufacturer Bias And Faltering Currency Create Challenges For Drugmakers - FEB 2016
Emerging Europe January 2016 / Belarus / Industry
Despite high forecasted growth in pharmaceutical sales and healthcare expenditure, Belarus will fail to attract investment from foreign pharmaceutical firms. Government policy to promote the use of...
Industry Trend Analysis - Investments From Multinational Drugmakers To Be Limited - JAN 2016
Emerging Europe November 2015 / Belarus / Industry
Investments by multinational pharmaceutical firms in Belarus will remain limited. Revenue prospects continue to be curtailed by the government's policy of favouring domestic drugmakers, creating an...
Industry Trend Analysis - Pharmaceutical Market To Remain Unattractive To Multinationals - MAY 2015
Emerging Europe April 2015 / Belarus / Industry
Belarus' pharmaceutical market will remain fundamentally unattractive to multinationals, given the limited per capita spending, protectionist policies towards domestic companies and its poor econom...
Industry Trend Analysis - Multinational Interest Will Not Increase Despite Positive Reform - APR 2015
Emerging Europe March 2015 / Belarus / Industry
While reforms to pharmaceutical legislation are positive, foreign interest and investment from Western drugmakers into Belarus will remain weak, given the risks present. We expect Indian companies...
Industry Trend Analysis - 2012 Sales Revised Upwards, But Market Continues To Hold Significant Risks - DEC 2013
Emerging Europe October 2013 / Belarus / Industry
We have revised our figures for the pharmaceutical market in Belarus owing to new historical data, indicating that sales grew more than previously expected. H113 data for pharmaceutical sales...